tiprankstipranks
NKGen Biotech (NKGN)
OTHER OTC:NKGN
US Market
NKGN
NKGen Biotech
RESEARCH TOOLSreports
Want to see NKGN full AI Analyst Report?

NKGen Biotech (NKGN) Income Statement

121 Followers

NKGen Biotech Income Statement

Last quarter (Q1 2025), NKGen Biotech's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q1, NKGen Biotech's net income was $15.35M. See NKGen Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 77.00K$ 426.00K
Gross Profit
$ 0.00$ 0.00$ 59.00K$ 396.00K
Operating Expenses
$ 26.97M$ 29.75M$ 24.41M$ 22.26M
Depreciation and Amortization
$ 0.00$ 1.20M$ 1.21M$ 1.24M
EBITDA
$ -26.97M$ -81.00M$ -23.23M$ -20.70M
Operating Income
$ -26.97M$ -29.75M$ -24.35M$ -21.86M
Other Income/Expenses
$ -17.27M$ -53.20M$ -2.40M$ -1.40M
Pretax Income
$ -44.23M$ -82.95M$ -26.75M$ -23.26M
Net Income
$ -44.29M$ -82.95M$ -26.75M$ -23.27M
Per Share Metrics
Basic EPS
$ -1.54$ -5.38$ -1.25$ -1.08
Diluted EPS
$ -1.54$ -5.38$ -1.25$ -1.08
Weighted Average Shares Outstanding
 28.83M 15.43M 21.45M 21.45M
Weighted Average Shares Outstanding (Diluted)
 28.83M 15.43M 21.45M 21.45M
Currency in USD

NKGen Biotech Earnings and Revenue History